###begin article-title 0
###xml 100 107 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 130 137 130 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
Prostaglandin F2alpha- and FAS-activating antibody-induced regression of the corpus luteum involves caspase-8 and is defective in caspase-3 deficient mice
###end article-title 0
###begin p 1
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 163 170 163 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 174 180 170 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 228 235 220 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 414 421 406 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 443 450 435 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 783 790 775 778 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 916 923 904 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 1118 1125 1106 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 1154 1161 1142 1145 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 1223 1230 1207 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 1342 1348 1320 1322 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 1499 1506 1469 1476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 1548 1555 1518 1521 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 1633 1640 1599 1606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 1753 1760 1719 1726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 1780 1787 1746 1753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 1894 1901 1860 1863 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 1958 1965 1920 1927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 2030 2037 1992 1995 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 2082 2089 2040 2047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 2143 2150 2101 2104 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 2171 2178 2125 2132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 2338 2345 2292 2299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
###xml 509 515 <span type="species:ncbi:9796">equine</span>
###xml 586 591 <span type="species:ncbi:9606">human</span>
###xml 1054 1058 <span type="species:ncbi:10090">mice</span>
###xml 1519 1523 <span type="species:ncbi:10090">mice</span>
###xml 1666 1670 <span type="species:ncbi:10090">mice</span>
###xml 1881 1885 <span type="species:ncbi:10090">mice</span>
We recently demonstrated that caspase-3 is important for apoptosis during spontaneous involution of the corpus luteum (CL). These studies tested if prostaglandin F2alpha (PGF2alpha) or FAS regulated luteal regression, utilize a caspase-3 dependent pathway to execute luteal cell apoptosis, and if the two receptors work via independent or potentially shared intracellular signaling components/pathways to activate caspase-3. Wild-type (WT) or caspase-3 deficient female mice, 25-26 days old, were given 10 IU equine chorionic gonadotropin (eCG) intraperitoneally (IP) followed by 10 IU human chorionic gonadotropin (hCG) IP 46 h later to synchronize ovulation. The animals were then injected with IgG (2 micrograms, i.v.), the FAS-activating antibody Jo2 (2 micrograms, i.v.), or PGF2alpha (10 micrograms, i.p.) at 24 or 48 h post-ovulation. Ovaries from each group were collected 8 h later for assessment of active caspase-3 enzyme and apoptosis (measured by the TUNEL assay) in the CL. Regardless of genotype or treatment, CL in ovaries collected from mice injected 24 h after ovulation showed no evidence of active caspase-3 or apoptosis. However, PGF2alpha or Jo2 at 48 h post-ovulation and collected 8 h later induced caspase-3 activation in 13.2 +/- 1.8% and 13.7 +/- 2.2 % of the cells, respectively and resulted in 16.35 +/- 0.7% (PGF2alpha) and 14.3 +/- 2.5% TUNEL-positive cells when compared to 1.48 +/- 0.8% of cells CL in IgG treated controls. In contrast, CL in ovaries collected from caspase-3 deficient mice whether treated with PGF2alpha , Jo2, or control IgG at 48 h post-ovulation showed little evidence of active caspase-3 or apoptosis. CL of WT mice treated with Jo2 at 48 h post-ovulation had an 8-fold increase in the activity of caspase-8, an activator of caspase-3 that is coupled to the FAS death receptor. Somewhat unexpectedly, however, treatment of WT mice with PGF2alpha at 48 h post-ovulation resulted in a 22-fold increase in caspase-8 activity in the CL, despite the fact that the receptor for PGF2alpha has not been shown to be directly coupled to caspase-8 recruitment and activation. We hypothesize that PGF2alpha initiates luteolysis in vivo, at least in part, by increasing the bioactivity or bioavailability of cytokines, such as FasL and that multiple endocrine factors work in concert to activate caspase-3-driven apoptosis during luteolysis.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 15 22 15 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 26 32 22 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 104 105 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 106 107 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 154 161 146 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 423 429 403 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 452 453 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 454 455 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 584 593 560 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 632 633 608 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 634 635 610 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 636 638 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 671 678 647 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 740 747 712 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Prostaglandin F2alpha (PGF2alpha) has been implicated as a luteolysin in a number of mammalian species [1-3]. However, the exact mechanism(s) by which PGF2alpha elicits its response in the corpus luteum (CL) remains unclear. Results from previous studies have implicated so-called death receptor-activating cytokines, such as tumor necrosis factor alpha (TNFalpha) and Fas ligand (FasL), as being important mediators of PGF2alpha-initiated luteolysis [4-6]. Unfortunately, since the vast majority of evidence supporting a role for cytokines in luteal regression has been derived from in vitro studies of dispersed cells in culture [5,7-14], it is currently unknown if PGF2alpha modulates death receptor-coupled signaling pathways in the CL in vivo.
###end p 3
###begin p 4
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 794 803 794 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 912 913 912 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 924 926 924 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 940 942 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 963 971 963 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1103 1105 1103 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 492 497 <span type="species:ncbi:9606">human</span>
###xml 700 704 <span type="species:ncbi:10090">mice</span>
###xml 714 718 <span type="species:ncbi:10116">rats</span>
###xml 893 898 <span type="species:ncbi:9606">human</span>
###xml 905 910 <span type="species:ncbi:10090">mouse</span>
###xml 919 922 <span type="species:ncbi:10116">rat</span>
###xml 935 938 <span type="species:ncbi:9913">cow</span>
###xml 1096 1101 <span type="species:ncbi:10090">mouse</span>
At least 29 TNF receptor super family members have been identified in the human [15] some of which have been deemed death receptors either by their action or because they contain the highly homologous amino acid sequence corresponding to death domain (DD) [15,16]. The FAS/FasL system was chosen for study herein because FAS is recognized as a death receptor and indirect evidence suggests that it plays a significant role in luteal regression. For example, FAS immunostaining is observed in human granulosa-lutein cells during the early luteal phase, and progressively intensifies during the mid-luteal phase through the late luteal phase [17]. This expression pattern is also observed in the CL of mice [18] and rats [19,20]. In keeping with the proposal that FAS plays a role in luteolysis, in vitro studies have shown that FasL or FAS-activating antibodies induce luteal cell death in the human [10], mouse [5,18], rat [19,20] and cow [21]. Moreover, limited in vivo work has demonstrated that intravenous or intraperitoneal administration of FAS-activating antibody causes luteolysis in the mouse [18].
###end p 4
###begin p 5
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr </italic>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 285 289 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gld </italic>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 401 404 401 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 405 409 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr </italic>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
###xml 759 765 <span type="species:ncbi:10090">murine</span>
Additional support for a functional role of FAS in luteal regression has been derived from experiments with homozygous lpr mice, which have non-functional or minimally-functional FAS [22]. The CL of these mice undergo regression, but at irregular intervals [18]. Similarly, homozygous gld mice, which lack expression of functional FasL [22], have an irregular luteal phase similar to that observed in lpr/lpr mice [18]. Unfortunately, no work was done to characterize potential apoptosis defects in the CL of these mutants, and thus the basis for the irregular cyclicity remains unknown. Collectively these results suggest that FAS-mediated events are critical to timely progression of the normal estrous cycle, and perhaps to luteal regression, in the adult murine ovary.
###end p 5
###begin p 6
###xml 71 77 71 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 232 240 228 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspases</italic>
###xml 327 330 323 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g</italic>
###xml 333 340 329 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 362 365 358 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g</italic>
###xml 368 375 364 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 408 410 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 506 513 502 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 565 567 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 632 638 628 630 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 665 673 657 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 746 753 738 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 781 788 773 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 475 480 <span type="species:ncbi:10090">mouse</span>
Thus it is conceivable that some level of cross-talk occurs between PGF2alpha-initiated events and death receptor function during the tissue involution process of the CL. Mechanistically, this would likely involve the activation of caspases, a family of aspartic acid-specific cysteine proteases that serve as both initiators (e.g., caspase-8) and executioners (e.g., caspase-3) of apoptosis in vertebrates [23]. Indeed, we have recently shown using a synchronized ovulation mouse model that activation of caspase-3 is required for structural involution of the CL [24]. The present study was designed to test the hypothesis that PGF2alpha-induced luteal regression in vivo is mediated through indirect mechanisms involving death receptor-coupled caspase-8 activation followed by a caspase-3-dependent pathway of apoptosis.
###end p 6
###begin title 7
Materials and Methods
###end title 7
###begin title 8
Animals
###end title 8
###begin p 9
###xml 19 28 19 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase-3</italic>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
Wild-type (WT) and caspase-3-deficient female mice (congenic C57BL/6) were generated by mating heterozygous male and female mice [25]. Female mice were genotyped by PCR analysis of tail-snip genomic DNA using specific primers [25]. Timed ovulation was induced in all experiments at day 25-26 postpartum by intraperitoneal injection of mice with 10 IU of eCG; (Professional Compounding Centers of America, Houston, TX) followed by 10 IU hCG; (Serono Laboratories, Randolph, MA) 46 h later [24]. This regime induces superovulation at approximately 10 hours post hCG with development of 8 to 10 CL per ovary. Peak progesterone synthesis occurs at approximately 30 hours post ovulation and levels fall back to preovulatory levels by approximately 60 hours (unpublished). All animal protocols were reviewed and approved by the Massachusetts General Hospital Institutional Animal Care and Use Committee, and were performed in strict accordance with the NIH Guide for the Care and Use of Laboratory Animals.
###end p 9
###begin title 10
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
In vivo studies of luteal regression
###end title 10
###begin p 11
###xml 67 74 67 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 349 356 347 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 784 791 776 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 809 817 801 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 928 935 920 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 142 147 <span type="species:ncbi:10090">mouse</span>
###xml 262 267 <span type="species:ncbi:10090">mouse</span>
###xml 303 308 <span type="species:ncbi:10090">mouse</span>
###xml 364 369 <span type="species:ncbi:10090">mouse</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
In these experiments, gonadotropin-synchronized mice (wild-type or caspase-3-null) were injected at 24 or 48 h post-ovulation with IgG (2 mug/mouse, i.v.; a non-activating Anti-FAS antibody; Santa Cruz Biotechnology, Santa Cruz, CA), the hamster monoclonal anti-mouse FAS-activating antibody Jo2 (2 mug/mouse, i.v.; PharMingen, San Diego, CA) or PGF2alpha (10 mug/mouse, i.p.; Lutalyse, Pharmacia-Upjohn Co., Kalamazoo, MI). Ovaries and blood were then collected at 8 h post-injection (n = 3 mice per genotype per treatment group). In some experiments, ovaries were fixed in 10% neutral-buffered formalin, paraffin-embedded, serially sectioned (6 mum) and mounted in order on glass microscope slides. Ovarian mid-sagittal sections were used for immunohistochemical analysis of active caspase-3 (see below) or in situ analysis of DNA fragmentation by TUNEL (see below). In other experiments, CL were homogenized and assessed for caspase-8 activity (see below). Serum was separated from blood samples and stored at -80 C until analysis for progesterone concentrations (see below).
###end p 11
###begin title 12
Immunohistochemistry
###end title 12
###begin p 13
###xml 104 111 104 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 295 302 295 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 514 521 514 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 665 672 665 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 817 824 817 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 889 896 889 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 937 944 937 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 1063 1070 1063 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 182 188 <span type="species:ncbi:9986">rabbit</span>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
###xml 957 961 <span type="species:ncbi:10090">mice</span>
###xml 1215 1219 <span type="species:ncbi:10090">mice</span>
Paraffin-embedded sections were analyzed by immunohistochemistry for the presence of cleaved ("active") caspase-3, as previously described [9,24,26,27] using a 1:3,000 dilution of a rabbit polyclonal antibody (CM1; IDUN Pharmaceuticals Inc., La Jolla, CA) that preferentially recognizes cleaved caspase-3 [9,24,26,27]. Sections were counterstained with hematoxylin and analyzed by light microscopy. Cells exhibiting red-brown cytoplasmic staining from the colorimetric reaction were considered positive for active caspase-3. Negative controls (reactions lacking primary antibody) yielded no reaction product (data not shown). Similarly, ovarian tissue samples from caspase-3 deficient mice exhibited minimal or no immunostaining (data not shown; see [24,26]), consistent with the fact that CM1 recognizes principally caspase-3 in addition to low cross-reactivity with processed ("active") caspase-7 [27]. Sections of ovaries from WT and caspase-3 deficient mice were always processed in parallel within the same assay. For quantitative comparisons, the number of caspase-3 positive cells was determined by counting CM-1 reactive cells in 3 fields of view (X600) per CL in three separate CL from each of 3 different mice per genotype per treatment group without knowledge of treatment.
###end p 13
###begin p 14
###xml 338 344 <span type="species:ncbi:9986">rabbit</span>
###xml 474 478 <span type="species:ncbi:9925">goat</span>
###xml 484 490 <span type="species:ncbi:9986">rabbit</span>
###xml 726 732 <span type="species:ncbi:9986">rabbit</span>
In addition, samples from the two groups were subjected to immunohistochemical analysis of FAS protein as per the manufacturer's instructions with slight modifications as listed below. Paraffin sections were subjected to microwave on high power for 10 minutes in sodium acetate, pH6, for antigen retrieval. Sections were incubated with a rabbit polyclonal FAS antibody (1:50; SC-1024; Santa Cruz Biotechnology, Santa Cruz, CA). The secondary antibody, peroxidase conjugated goat anti-rabbit IgG was applied at a dilution of 1:200. The sections were then stained with 3,3'-diaminobenzidine tetrahydrochloride (DAB) to identify FAS positive cells. Controls included sections treated in the same manner but incubated with normal rabbit serum instead of primary antibody. All immunohistochemical staining for any given antibody was done on all sections at the same time under the same conditions.
###end p 14
###begin title 15
Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)
###end title 15
###begin p 16
###xml 120 127 120 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 496 503 496 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 516 520 <span type="species:ncbi:10090">mice</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
The occurrence of apoptosis in luteal and ovarian sections was assessed by monitoring the presence of DNA fragmentation in situ, as described previously [28]. Slides were analyzed by light microscopy after light counterstaining with hematoxylin. Cells exhibiting dark brown nuclear staining from the colorimetric reaction were considered positive for DNA fragmentation. Negative controls, lacking the labeling enzyme, yielded no reaction product (data not shown). Sections of ovaries from WT and caspase-3 deficient mice were processed for TUNEL in parallel within the same assay. The percent of apoptotic cells was determined by counting TUNEL-positive cells out of the total number of cells per three fields of view (X600) in each of three CL from each of 3 different mice per genotype per treatment group.
###end p 16
###begin title 17
Caspase-8 activity assay
###end title 17
###begin p 18
###xml 61 68 61 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
Ovaries were removed 8 h post-treatment with IgG, Jo2, or PGF2alpha and CL were dissected out using a dissecting microscope. All CL from an individual animal were pooled and homogenized in lysis buffer from the ApoAlert Caspase-8 Colorimetric Assay Kit (Clontech, Palo Alto, CA). The protein content was determined using the DC protein determination assay (BioRad, Hercules, CA). Samples were diluted to 2 mug protein/ml with dilution buffer supplied in the kit. Fifty mul of each diluted sample (100 ng protein/sample) was then incubated with 200 muM IETD-pNA substrate for 2 h at 37 C in the dark, and the reaction product was determined by reading the absorbance at 405 nm.
###end p 18
###begin title 19
Serum hormone analysis
###end title 19
###begin p 20
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
Progesterone levels were measured in serum according to the manufacturer's instructions using a direct solid phase enzyme-immunoassay (DRG Progesterone ELISA kit; ALPCO, Windham, NH), as previously validated in our laboratory [24].
###end p 20
###begin title 21
Data Presentation and Statistical Analysis
###end title 21
###begin p 22
###xml 255 256 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 358 360 356 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Each experiment was independently replicated three times with different mice in each experiment. Qualitative data shown are representative of results obtained in the replicate experiments. Quantitative data (mean +/- SEM) were analyzed by either Students t-test or one-way ANOVA followed by Duncan's New Multiple Range test when differences were observed. A P value less than 0.05 was considered statistically significant.
###end p 22
###begin title 23
Results
###end title 23
###begin title 24
###xml 77 83 77 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
Caspase-3 is required for apoptosis in CL following treatment with Jo2 or PGF2alpha
###end title 24
###begin p 25
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 197 204 197 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 372 374 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 456 458 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 466 473 460 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 479 481 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 630 636 618 620 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 654 656 636 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 850 857 832 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 928 930 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 953 960 933 936 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 966 968 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1F</xref>
###xml 1031 1033 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 877 881 <span type="species:ncbi:10090">mice</span>
There was no evidence of TUNEL-positive cells in the CL of ovaries collected from WT or caspase-3-null mice following treatment at 24 h post-ovulation with IgG, FAS-activating antibody (Jo2) or PGF2alpha (data not shown). The percentage of TUNEL-positive cells in CL of ovaries collected from WT mice following IgG injection at 48 h post-ovulation was 1.48 +/- 0.8% (Fig. 1A). By comparison, the CL in ovaries collected from WT mice treated with Jo2 (Fig. 1C) or PGF2alpha (Fig. 1E) at 48 h post-ovulation exhibited a 10-fold or greater increase in the percentage of TUNEL-positive cells per field of view (Jo2: 14.3 +/- 2.5%; PGF2alpha: 16.35 +/- 0.7%; P < 0.05 for both treatments versus IgG controls). In striking contrast to the results with WT mice, there was no significant increase in the percentage of TUNEL-positive cells in CL derived from caspase-3 deficient female mice treated at 48 h post-ovulation with Jo2 (Fig. 1D; 0.32 +/- 0.17) or PGF2alpha (Fig. 1F; 0.22 +/- 0.08) when compared with IgG-treated controls (Fig. 1B; 0.06 +/- .003).
###end p 25
###begin p 26
###xml 64 71 64 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 124 130 124 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 287 293 283 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">brown </italic>
###xml 360 367 356 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 453 460 449 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
Histochemical assessment of apoptosis in CL derived from WT and caspase-3-null mice following treatment with IgG, Jo2 or PGF2alpha, each administered at 48 h post-ovulation. The ovaries were harvested 8 h post-injection. The data shown depict the incidence of apoptotic (TUNEL-positive, brown staining) cells in CL of ovaries derived from WT (A, C, and E) and caspase-3 deficient mice (B, D, and F) following injection with IgG (A, B), Jo2 (C, D) or PGF2alpha (E, F). Original magnifications, x 600. The insets represent a higher magnification (x 1000), demonstrating the presence or absence of TUNEL positive cells. The photomicrographs shown are representative of similar results obtained in at least three independent experiments.
###end p 26
###begin title 27
###xml 10 17 10 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 34 41 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Jo2 or PGF2alpha increases active caspase-3 enzyme levels in CL of WT mice
###end title 27
###begin p 28
###xml 86 93 86 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 200 207 200 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 395 397 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 479 481 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 489 496 483 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 502 504 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 651 657 639 641 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 674 676 656 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 804 811 786 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 882 884 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 897 899 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 907 914 889 892 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 920 922 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F</xref>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
There was no evidence of CM1-positive cells in the CL of ovaries collected from WT or caspase-3 deficient mice following treatment at 24 h post-ovulation with IgG, FAS-activating antibody (Jo2) or PGF2alpha (data not shown). The percentage of CM1-positive cells per field of view in CL of ovaries collected from WT mice following IgG injection at 48 h post-ovulation was low (1.3 +/- 0.3%; Fig. 2A). By comparison, the CL in ovaries collected from WT mice treated with Jo2 (Fig. 2C) or PGF2alpha (Fig. 2E) at 48 h post-ovulation exhibited a 10-fold or greater increase in the percentage of CM1-positive cells per field of view (Jo2: 13.7 +/- 2.2%; PGF2alpha: 13.2 +/- 1.8%; P < 0.05 for both treatments versus IgG controls). As anticipated, there was no evidence of CM1-positive cells in CL derived from caspase-3 deficient female mice treated at 48 h post-ovulation with IgG (Fig. 2B), Jo2 (Fig. 2D) or PGF2alpha (Fig. 2F).
###end p 28
###begin p 29
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 121 127 121 123 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 152 159 148 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 257 264 253 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 369 376 365 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
Detection of active caspase-3 in CL derived from WT and caspase-3-deficient mice following treatment with IgG, Jo2 or PGF2alpha. The presence of active caspase-3 was evaluated by immunohistochemistry using CM-1 antibody in sections of CL derived from WT or caspase-3-deficient mice 8 h following injection at 48 h post ovulation with IgG (A and B), Jo2 (C and D) or PGF2alpha (E and F). Original magnification: x 600. The insets represent a high magnification (original magnification x 1000) demonstrating the presence or absence of CM-1 positive cells (dark brown reaction). Medial sections were obtained from CL from three independent mice for analysis. Photomicrographs shown are representative of identical results in at least three separate experiments.
###end p 29
###begin title 30
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Immunohistochemical detection of FAS in WT and caspase-3 deficient mice
###end title 30
###begin p 31
###xml 72 79 72 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 175 182 171 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 371 373 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 379 386 375 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 400 402 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
To rule out the possibility that the lack of effect of either Jo2 or PGF2alpha injected at 24 h post-ovulation was due to the lack of FAS expression in the CL of either WT or caspase-3 deficient mice, ovarian sections from both groups were subjected to immunohistochemical analysis of FAS protein. FAS was evident in luteal tissue of ovaries collected from both WT (Fig. 3B) and caspase-3-null (Fig. 3C) mice at 24 h post-ovulation.
###end p 31
###begin p 32
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 123 129 123 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 399 406 395 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 273 278 <span type="species:ncbi:10090">mouse</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
Histochemical assessment of FAS in CL derived from WT and caspase-3-deficient mice following treatment with IgG, Jo2 or PGF2alpha. administered 24 h post ovulation and ovaries harvested 8 h post injection. Panel represents a photomicrograph of a CL section derived from WT mouse used as a negative control (no primary antibody). Panel B and C are photomicrographs of CL sections derived from WT and caspase-3-deficient mice (respectively) probed with anti-FAS antibody. Original magnification for panels A, B and C x 600.
###end p 32
###begin title 33
###xml 32 39 32 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Serum levels of progesterone in caspase-3 deficient versus WT mice
###end title 33
###begin p 34
###xml 173 180 169 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 255 257 245 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 321 328 311 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 441 448 425 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
There was no significant difference in the levels of progesterone in WT mice at 8 hours following injection with IgG (4.14 +/- 1.09 ng/ml), Jo2 (4.90 +/- 2.26 ng/ml), or PGF2alpha (4.66 +/- 1.08 ng/ml) at 24 hours. In addition, no significant difference (P > 0.05) in the levels of progesterone was observed in WT versus caspase-3-null (ko) mice at 8 h after injection with IgG 2.76 +/- 1.26, Jo2 (wt, 1.25 +/- 0.34; ko 1.49 +/- 0.63) or PGF2alpha (wt, 2.7 +/- 0.8; ko, 3.7 +/- 0.31) at the 48 h post-ovulation time-points.
###end p 34
###begin title 35
Caspase-8 activity
###end title 35
###begin p 36
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 173 179 173 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 256 258 252 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 269 276 265 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 324 325 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 350 356 346 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 394 396 386 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 409 416 401 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 448 449 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
In a final set of experiments, the level of caspase-8 activity was determined in CL isolated from ovaries collected from WT mice 8 h following injection with IgG, Jo2 or PGF2alpha, at 48 h post-ovulation. Treatment with Jo2 resulted in an 8-fold increase (P < 0.04) in caspase-8 activity over the IgG treated controls (Fig. 4). In addition, CL of PGF2alpha-treated mice had a 22-fold increase (P < 0.0003) in caspase-8 activity over controls (Fig. 4).
###end p 36
###begin p 37
###xml 80 87 80 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 87 94 83 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 109 116 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 255 262 249 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
Quantitative analysis of Caspase-8 activity in CL in response to IgG, Jo2 or PGF2alpha in vivo. The level of caspase-8 activity was determined in CL isolated from ovaries collected from WT mice 8 h following injection IgG (2 mug/IV), Jo2 (2 mug/IV) or PGF2alpha (10 mug/IP). The asterisk (*) represent differences from the control P < 0.05. The experiment was replicated three separate times (n = 3) with different groups of mice.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 15 22 15 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 169 170 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 171 172 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 192 199 188 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 421 429 413 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 436 445 428 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 491 498 483 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 498 506 486 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 630 632 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 633 635 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 669 676 657 660 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 676 685 660 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 775 777 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 778 780 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 793 795 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 796 798 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 861 863 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 864 866 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 909 916 893 896 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 926 934 906 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 1062 1069 1042 1045 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 1319 1325 1291 1293 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 1367 1368 1335 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1369 1370 1337 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1371 1373 1339 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1374 1376 1342 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1377 1379 1345 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1443 1450 1411 1414 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 1692 1699 1656 1659 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 1827 1829 1787 1789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1917 1924 1877 1880 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 1964 1971 1920 1927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 2152 2159 2108 2111 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 755 758 <span type="species:ncbi:10116">rat</span>
###xml 767 773 <span type="species:ncbi:9913">bovine</span>
###xml 786 791 <span type="species:ncbi:9606">human</span>
###xml 1479 1484 <span type="species:ncbi:10090">mouse</span>
###xml 1601 1604 <span type="species:ncbi:10116">rat</span>
###xml 1665 1670 <span type="species:ncbi:10090">mouse</span>
###xml 1715 1720 <span type="species:ncbi:10090">mouse</span>
###xml 1981 1985 <span type="species:ncbi:10090">mice</span>
Prostaglandin F2alpha has long been proposed to disrupt progesterone synthesis, decrease blood flow, increase stress-related signaling, and induce cell death in the CL [2,3]. However, that PGF2alpha serves as a sole direct regulator of all aspects of luteal regression remains debatable, due in large part to discordant data resulting from species-specific differences in the control of CL function or from studies using in vivo versus in vitro approaches. For example, administration of PGF2alpha in vivo results in a decline in serum progesterone concentrations and an induction of luteal cell apoptosis in a number of species [29-33]. In contrast, treatment with PGF2alpha in vitro decreases gonadotropin-stimulated progesterone production in cultured rat, ovine, bovine [34-36] and human [37-40] luteal cells, but does not effect cell numbers or viability [35,41]. The loss of pro-apoptotic effects of PGF2alpha following ex vivo removal and chemical dispersal of the CL suggest that either other endocrine factors or cell-to-cell contact is required for PGF2alpha to kill luteal cells. While interaction between endothelial cells and steroidogenic luteal cells is probably important, recent data support the former possibility as well in that key roles for death receptor ligands, such as FasL and TNFalpha, in PGF2alpha-initiated luteolysis have been proposed [5,7,18-20,42]. Careful consideration should also be given to the role of PGF2alpha as a luteolytic agent in the mouse. Although it is arguably a primary luteolysin in a number of species and may serve as a secondary luteolysin in the rat, its role as a primary or secondary luteolytic agent in the mouse is uncertain. The PGF2alpha receptor mutant mouse appears to have a normal length estrous cycle, however luteal regression fails to occur during pregnancy [43]. It is not readily clear if the functional and structural components differ in the PGF2alpha receptor mutant as are described in the caspase-3 mutant mice. Of course it is also possible that there are redundant mechanisms which may serve to propagate the luteolytic signal during the estrous cycle in the absence of a PGF2alpha receptor.
###end p 39
###begin p 40
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 433 440 433 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 637 644 637 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 860 867 860 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 947 948 947 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 949 951 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 952 954 952 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1033 1040 1033 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 1193 1195 1193 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1238 1245 1238 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 197 202 <span type="species:ncbi:10090">mouse</span>
###xml 687 691 <span type="species:ncbi:10090">mice</span>
###xml 809 814 <span type="species:ncbi:9606">human</span>
###xml 816 822 <span type="species:ncbi:9913">bovine</span>
###xml 824 827 <span type="species:ncbi:10116">rat</span>
###xml 832 837 <span type="species:ncbi:10090">mouse</span>
###xml 1048 1052 <span type="species:ncbi:10090">mice</span>
To more easily study the events underlying the functional and structural components of luteal regression, which are temporally distinct, we have utilized the gonadotropin-synchronized luteal phase mouse model. In this model, we have found that circulating levels of progesterone peak at 30 h post-ovulation and precipitously decline to pre-luteal phase levels by 60 h after ovulation [24]. Structural involution of the CL occurs via caspase-3-mediated apoptosis around 48 h post-ovulation, as evidenced by a dramatic increase in TUNEL positive cells concomitant with the rapid decline in progesterone secretion [24]. The requirement for caspase-3, determined by the use of gene knockout mice, is consistent with reports that this executioner of apoptosis is expressed in the CL of many species, including the human, bovine, rat and mouse [24,44-46]. Moreover, caspase-3-like activity is up-regulated during luteal regression or luteal cell death [9,44,47]. Interestingly, however, whereas the levels of serum progesterone decline in caspase-3-null mice similar to their wild-type siblings during luteolysis, structural involution of the CL is suspended for at least 4 d in the mutant animals [24]. This study provided strong evidence for caspase-3 being paramount to structural involution but not loss of function (decreased progesterone) of the CL.
###end p 40
###begin p 41
###xml 103 110 103 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 154 161 150 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 288 295 284 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 507 514 499 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 660 662 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 728 735 720 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 795 802 787 790 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 811 819 799 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 922 929 910 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 961 967 949 951 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 748 752 <span type="species:ncbi:10090">mice</span>
Using this ovulation-synchronized mouse model, in the present study we found that administration of PGF2alpha to WT female mice or their mutant siblings (caspase-3 deficient) at 24 or 48 h post-ovulation had no effect on progesterone levels versus controls. However, administration of PGF2alpha at 48 h post-ovulation resulted in a dramatic acceleration in the onset of apoptosis when compared to CL in untreated controls. This effect was mirrored by a proportional increase in the incidence of CM1 (active caspase-3)-positive cells in the CL, consistent with the hypothesis that this enzyme is important for cell death during structural involution of the CL [24]. These findings were extended by demonstrating that the CL from caspase-3 deficient mice were resistant to apoptosis induced by PGF2alpha exposure in vivo when compared to CL of WT type siblings treated in parallel. These data unequivocally demonstrate that caspase-3 is a required mediator of PGF2alpha-induced luteolysis.
###end p 41
###begin p 42
###xml 83 90 83 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 212 220 212 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 389 395 389 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 605 612 601 604 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 646 653 638 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 760 767 752 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 806 808 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 896 903 888 891 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 903 911 891 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 987 994 975 978 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 995 997 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 998 1000 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1117 1124 1101 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 1128 1130 1112 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 1186 1193 1170 1173 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 1205 1212 1185 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Of interest, comparable results were obtained following injection of wild-type and caspase-3 deficient mice at 48 h post-ovulation with Jo2 antibody, an approach used routinely to activate the FAS death receptor in vivo [48,49]. The concentration of Jo2 used herein the present study has been shown to be sublethal [48]. The lack of a pro-apoptotic effect of Jo2, or for that matter of PGF2alpha, when injected at 24 h post-ovulation could not be attributed to lack of FAS since the receptor was present in CL derived from all treatment groups regardless of genotype. Of further interest, both Jo2 and PGF2alpha induced a significant increase in caspase-8 activity in CL homogenates. While FAS-mediated signaling clearly involves recruitment and activation of caspase-8 in all cell types analyzed to date [50], the finding that activity of this enzyme in the CL was so dramatically induced by PGF2alpha in vivo was a surprise. Sequence analysis indicates that the cloned receptor for PGF2alpha [51,52] does not contain a death-domain (DD), the structural motif found in death receptors that are capable of activating caspase-8 [50]. Therefore, we can only deduce that the ability of PGF2alpha to increase caspase-8 activity is indirectly due to its local modulation of death receptor activation in the CL.
###end p 42
###begin p 43
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 471 474 471 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 475 479 475 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr </italic>
###xml 532 538 532 534 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 608 611 604 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 612 616 608 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr </italic>
###xml 803 805 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 873 879 869 871 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 944 950 936 938 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 997 1005 985 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1011 1018 999 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 1130 1137 1118 1121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945; </sub>
###xml 1299 1305 1283 1285 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 168 173 <span type="species:ncbi:10090">mouse</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
Such a concept would be in keeping with studies of estrous cyclicity in mice lacking functional FAS [18], FasL [18] or TNF receptors [53]. In all three of these mutant mouse lines, luteal phase defects and/or aberrant estrous cycles have been reported. While such findings lend support to the importance of death receptor signaling in normal luteal regression, the disrupted follicular dynamics and ovarian function in these mutants also hindered our attempts to examine lpr/lpr mice (Jackson Laboratories) for defects in either PGF2alpha-induced luteal regression or luteal cell apoptosis. In our hands the lpr/lpr mice failed to consistently respond to gonadotropin stimulation as did their wild type siblings (data not shown) lending further support to their irregular cyclicity reported previously [18]. Nonetheless, in light of the data presented, we conclude that PGF2alpha, along with pro-apoptotic cytokines activated in response to PGF2alpha, work in concert to orchestrate luteal demise in vivo via a caspase-3-dependent pathway of apoptosis. Our current efforts are directed at determining the mechanism(s) by which PGF2alpha up-regulates the activity of death receptor function in the CL, as well as which specific death ligand-receptor family members are expressed, and modulated by PGF2alpha, in the CL.
###end p 43
###begin title 44
Acknowledgments
###end title 44
###begin p 45
We thank Dr. Anu Srinivasan (IDUN Pharmaceuticals, Inc., La Jolla, CA) for generously providing the CM1 antibody, and we are indebted to Mr. Sam Riley (Massachusetts General Hospital) for outstanding technical assistance with the image analysis and data presentation.
###end p 45
###begin p 46
*This work was supported by NIH grant R01-HD35934 (B.R.R.) and Vincent Memorial Research Funds (B.R.R., J.L.T.). This work was conducted while S.F.C. was a Doctoral candidate supported by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) of the Brazilian Government Foundation, and while T.M. was a Postdoctoral Research Fellow supported by the Finnish Foundation for Pediatric Research and the Finnish Cultural Foundation. J.K.P. completed this work while he was a Lalor Foundation Fellow. R.A.F. is an Investigator of the Howard Hughes Medical Institute. J.L.T. is an Investigator at the Steven and Michele Kirsch Foundation.
###end p 46
###begin article-title 47
Molecular control of luteal secretion of progesterone.
###end article-title 47
###begin article-title 48
Mechanisms controlling the function and life span of the corpus luteum.
###end article-title 48
###begin article-title 49
Luteolysis: a neuroendocrine-mediated event.
###end article-title 49
###begin article-title 50
Immune cells in the corpus luteum: friends or foes?
###end article-title 50
###begin article-title 51
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Responsiveness of mouse corpora luteal cells to Fas antigen (CD95)-mediated apoptosis.
###end article-title 51
###begin article-title 52
Potential roles of tumor necrosis factor-alpha in follicular development, ovulation, and the life span of the corpus luteum.
###end article-title 52
###begin article-title 53
###xml 49 55 <span type="species:ncbi:9913">bovine</span>
Mechanisms of cytokine-induced death of cultured bovine luteal cells.
###end article-title 53
###begin article-title 54
###xml 53 59 <span type="species:ncbi:9913">bovine</span>
Mediators of interferon gamma-initiated signaling in bovine luteal cells.
###end article-title 54
###begin article-title 55
Stress-induced mitogen-activated protein kinase signaling in the corpus luteum.
###end article-title 55
###begin article-title 56
###xml 34 39 <span type="species:ncbi:9606">human</span>
Fas antigen-mediated apoptosis in human granulosa/luteal cells.
###end article-title 56
###begin article-title 57
###xml 143 148 <span type="species:ncbi:9606">human</span>
Interactions between interferon gamma, tumour necrosis factor alpha, and interleukin-1 in modulating progesterone and oestradiol production by human luteinized granulosa cells in culture.
###end article-title 57
###begin article-title 58
###xml 86 91 <span type="species:ncbi:9606">human</span>
Cytokine modulation of progesterone and estradiol secretion in cultures of luteinized human granulosa cells.
###end article-title 58
###begin article-title 59
###xml 35 41 <span type="species:ncbi:9913">bovine</span>
Tumor necrosis factor-alpha alters bovine luteal cell synthetic capacity and viability.
###end article-title 59
###begin article-title 60
###xml 83 88 <span type="species:ncbi:9606">human</span>
Gonadotropins and cytokines affect luteal function through control of apoptosis in human luteinized granulosa cells.
###end article-title 60
###begin article-title 61
The molecular architecture of the TNF superfamily.
###end article-title 61
###begin article-title 62
TNF receptor subtype signalling: Differences and cellular consequences.
###end article-title 62
###begin article-title 63
###xml 68 74 <span type="species:ncbi:9606">infant</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
Immunological evidence for the expression of the Fas antigen in the infant and adult human ovary during follicular regression and atresia.
###end article-title 63
###begin article-title 64
Involvement of Fas antigen in ovarian follicular atresia and luteolysis.
###end article-title 64
###begin article-title 65
###xml 76 79 <span type="species:ncbi:10116">rat</span>
Fas and Fas ligand messenger ribonucleic acid and protein expression in the rat corpus luteum during apoptosis-mediated luteolysis.
###end article-title 65
###begin article-title 66
Requirement of the Fas ligand-expressing luteal immune cells for regression of corpus luteum.
###end article-title 66
###begin article-title 67
###xml 56 62 <span type="species:ncbi:9913">bovine</span>
Fas-mediated activation of the sphingomyelin pathway in bovine steroidogenic luteal cells.
###end article-title 67
###begin article-title 68
Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease.
###end article-title 68
###begin article-title 69
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
Mechanisms of caspase activation and inhibition during apoptosis.
###end article-title 69
###begin article-title 70
Caspase-3 is a pivotal mediator of apoptosis during regression of the ovarian corpus luteum.
###end article-title 70
###begin article-title 71
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice.
###end article-title 71
###begin article-title 72
Caspase-3 gene knockout defines cell lineage specificity for programmed cell death signaling in the ovary.
###end article-title 72
###begin article-title 73
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system.
###end article-title 73
###begin article-title 74
###xml 79 85 <span type="species:ncbi:9913">bovine</span>
Expression of superoxide dismutase, catalase and glutathione peroxidase in the bovine corpus luteum: Evidence supporting a role for oxidative stress in luteolysis.
###end article-title 74
###begin article-title 75
Effect of dose of prostaglandin F2alpha on steroidogenic components and oligonucleosomes in ovine luteal tissue.
###end article-title 75
###begin article-title 76
###xml 38 44 <span type="species:ncbi:9913">cattle</span>
Apoptosis during luteal regression in cattle.
###end article-title 76
###begin article-title 77
Internucleosomal DNA fragmentation in ovine luteal tissue associated with luteolysis: in vivo and in vitro analyses.
###end article-title 77
###begin article-title 78
###xml 54 68 <span type="species:ncbi:10036">golden hamster</span>
Apoptosis during spontaneous luteolysis in the cyclic golden hamster: biochemical and morphological evidence.
###end article-title 78
###begin article-title 79
###xml 65 68 <span type="species:ncbi:10116">rat</span>
Apoptosis-associated gene expression in the corpus luteum of the rat.
###end article-title 79
###begin article-title 80
###xml 108 111 <span type="species:ncbi:10116">rat</span>
Role of prostaglandin F2alpha in modulation of LH-stimulated steroidogenesis in vitro in different types of rat and ewe corpora lutea.
###end article-title 80
###begin article-title 81
###xml 89 95 <span type="species:ncbi:9913">bovine</span>
Effects of prostaglandin F2 alpha on agonist-induced progesterone production in cultured bovine luteal cells.
###end article-title 81
###begin article-title 82
###xml 146 150 <span type="species:ncbi:10116">rats</span>
Luteal membrane binding of prostaglandin F2 alpha and sensitivity of corpora lutea to prostaglandin F2 alpha-induced luteolysis in pseudopregnant rats.
###end article-title 82
###begin article-title 83
###xml 44 49 <span type="species:ncbi:9606">human</span>
Mode of action of prostaglandin F2 alpha in human luteinized granulosa cells: role of protein kinase C.
###end article-title 83
###begin article-title 84
###xml 53 58 <span type="species:ncbi:9606">human</span>
Prostaglandin F2 alpha activates protein kinase C in human ovarian cells.
###end article-title 84
###begin article-title 85
###xml 69 75 <span type="species:ncbi:9913">bovine</span>
Differential effects of prostaglandin F2alpha on in vitro luteinized bovine granulosa cells.
###end article-title 85
###begin article-title 86
###xml 116 121 <span type="species:ncbi:9606">human</span>
Interaction of prostaglandin F2alpha and gonadotropin-releasing hormone on progesterone and estradiol production in human granulosa-luteal cells.
###end article-title 86
###begin article-title 87
Cellular components involved in luteolysis.
###end article-title 87
###begin article-title 88
###xml 84 90 <span type="species:ncbi:9913">bovine</span>
Secretion of monocyte chemoattractant protein-1 (MCP-1) by endothelial cells of the bovine corpus luteum: Regulation by cytokines but not prostaglandin F2 alpha.
###end article-title 88
###begin article-title 89
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Failure of parturition in mice lacking the prostaglandin F receptor.
###end article-title 89
###begin article-title 90
###xml 16 23 16 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
###xml 70 77 70 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase</italic>
Accumulation of caspase-3 messenger ribonucleic acid and induction of caspase activity in the ovine corpus luteum following prostaglandin F2alpha treatment in vivo.
###end article-title 90
###begin article-title 91
###xml 17 20 <span type="species:ncbi:10116">rat</span>
Caspase-3 in the rat ovary: localization and possible role in follicular atresia and luteal regression.
###end article-title 91
###begin article-title 92
Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes.
###end article-title 92
###begin article-title 93
###xml 17 25 17 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspases</italic>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Mitochondria and caspases in induced apoptosis in human luteinized granulosa cells.
###end article-title 93
###begin article-title 94
Role of acidic sphingomyelinase in Fas/CD95-mediated cell death.
###end article-title 94
###begin article-title 95
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Acute toxicity of an anti-Fas antibody in mice.
###end article-title 95
###begin article-title 96
Molecular mechanisms of death-receptor-mediated apoptosis.
###end article-title 96
###begin article-title 97
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Cloning and expression of a cDNA for mouse prostaglandin F receptor.
###end article-title 97
###begin article-title 98
###xml 15 18 <span type="species:ncbi:10116">rat</span>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 88 91 <span type="species:ncbi:10116">rat</span>
Cloning of the rat and human prostaglandin F2 alpha receptors and the expression of the rat prostaglandin F2 alpha receptor.
###end article-title 98
###begin article-title 99
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Alterations of events related to ovarian function in tumor necrosis factor receptor type I knockout mice.
###end article-title 99

